Repligen | RGEN - Interest Expense On Debt



Repligen reported $5.35M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Agilent USD 28M 1000K Jul/2025
Align Technology 0 0 Sep/2024
Bio Techne USD 2.01M 141K Mar/2025
BioMarin Pharmaceutical USD 2.68M 184K Jun/2025
Bristol-Myers Squibb USD 485M 9M Jun/2025
Bruker USD 15.7M 2.6M Jun/2025
Charles River Laboratories USD 29.97M 2.08M Jun/2025
Danaher USD 71M 1000K Jun/2025
Dentsply International USD 24M 1000K Jun/2025
Exact Sciences USD 9.83M 143K Jun/2025
General Electric Aerospace USD 158M 52M Jun/2025
Henry Schein USD 38M 3M Jun/2025
Illumina USD 25M 0 Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
Mettler Toledo International USD 16.78M 126K Jun/2025
Myriad Genetics USD 800K 100K Mar/2025
Pfizer USD 654M 0 Jun/2025
Repligen USD 5.35M 104K Jun/2025
Revvity USD 22.94M 27K Jun/2025
Standard Biotools USD 9K 3.31M Jun/2025
Thermo Fisher Scientific USD 404M 101M Jun/2025
Waters USD 14.35M 84K Jun/2025
West Pharmaceutical Services USD 100K 300K Jun/2025